Two Sigma Securities, LLC Virios Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

  • $8.19 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.86 - $2.42 $19,433 - $54,684
22,597 New
22,597 $20,000
Q4 2022

Feb 14, 2023
BUY
$0.24 - $0.39 $2,215 - $3,600
9,233 Added 81.65%
20,541 $4,000
Q3 2022

Nov 14, 2022
BUY
$0.37 - $8.77 $4,183 - $99,171
11,308 New
11,308 $4,000

Others Institutions Holding VIRI

# of Institutions
27
Shares Held
991K
Call Options Held
0
Put Options Held
0
View Full List

About Virios Therapeutics, Inc.

VIRI Quotes by TradingView
  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $3.12M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email